Futermestotug
Based on 1 Customer Validation
Futermestotug is a humanized immunoglobulin G1-κ monoclonal antibody targeting human cytotoxic T-lymphocyte associated protein 4 (CTLA4). Futermestotug is promising for research of various malignant tumors.
For research use only. We do not sell to patients.
- Purity: 99.84%
- CAS No.: 3014361-57-7
- Molecular Weight:145.815 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Human IgG1 kappa
Human
CTLA4
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG1-kappa
ELISA, FACS, Functional assay
-
Immobilized CTLA-4 Protein, Human (HEK293, HY-P72959) can bind Futermestotug. The EC50 for this effect is 21.03 ng/mL.
Chemical Information
-
CAS No. 3014361-57-7
-
Appearance Liquid
-
Molecular Weight 145.815 kDa
-
Color Colorless to light yellow
-
SMILES
[Futermestotug]
-
Synonyms
YH-001; C-17226
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (254 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)